When was Sirigen founded?

Sirigen was founded in 2003 and raised its 1st funding round 5 years after it was founded.

Where is Sirigen located?

Sirigen is headquartered in San Diego, United States.

How many employees does Sirigen have?

As of Jul 01, 2024, the latest employee count at Sirigen is 11 - 50.

Is Sirigen a funded company?

Sirigen is a funded company, having raised a total of $12.1M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 30, 2008.

When was the latest funding round of Sirigen?

Sirigen's latest funding was a $***** Series B round on Oct 2010, with participation from 5 investors.

Where does Sirigen rank among its competitors?

Sirigen ranks 39th amongst 724 active competitors, of which 48 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Cayman Chem, which secured $307K in Apr, 2025.

Who are the top competitors of Sirigen?

Sirigen's top competitors include Meridian Bioscience, Abcam and Enzo. Among them, Cayman Chem secured the most recent funding round in April, 2025.

Sirigen - 2026 Company Profile, Team, Funding & Competitors

Company Details

Sirigen develops high sensitivity fluorescence detection technologies for diagnostic and life science applications. Its platform technology uses novel polymer chains to increase fluorescence sensitivity in traditional assays. The company makes a range of products to be used with immunoassays, flow cytometry, proteomics, molecular diagnostics, microarrays, imaging, and other assays.

Website: sirigen.com
Phone Number: +1 **********

Key Metrics

Founded Year

2003

Location

San Diego, United States

Stage

Acquired

Total Funding

$12.1M in 3 rounds

Latest Funding Round

Series B, Oct 2010, $*****

Investors

Oxford Capital & 8 more

Ranked

39^th among 724 active competitors

Employee Count

11 - 50 as on Jul 01, 2024

Similar Companies

Montana Molecular & 23 more

Exit Details

Acquired by Becton Dickinson (Aug 27, 2012)

View Sirigen's full profile

Sirigen is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sirigen Inc CIN: 45-0499748 , United States, Active		-	-	-

Sirigen got acquired by Becton Dickinson on Aug 27, 2012.

Click here to take a look at Sirigen's acquisition in detail

Sirigen has raised a total funding of $12.1M over 3 rounds. Its first funding round was on Apr 30, 2008. Its latest funding round was a Series B round on Oct 2010 for $*****. 5 investors participated in its latest round. Sirigen has 9 institutional investors.

Here is the list of recent funding rounds of Sirigen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 2010	3890008	Series B	1326122	9364848	9094639	8530066
May 14, 2009	8994215	Series A	6674314	2510286	6383040	7675668
Apr 30, 2008	4597579	Series A	6014299	8545879	Seraphim & 1 more	3891924

Access funding benchmarks and valuations. Sign up today!

View details of Sirigen's funding rounds and investors

The founders of Sirigen is Patrick Dietzen. Nick Kerton is the CEO of Sirigen.

Here are the details of Sirigen's key team members:

Patrick Dietzen: President / Founder / Director of Sirigen.
Nick Kerton: CEO of Sirigen.
Contact Info: 1 email address

View details of Sirigen's Founder profiles and Board Members

Sirigen's employee count trend

Sirigen has 11 - 50 employees as of Jul 24. Here is Sirigen's employee count trend over the years:

Uncover Sirigen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sirigen include Meridian Bioscience, Abcam and Enzo. Here is the list of Top 10 competitors of Sirigen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
2nd	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	64/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	60/100
4th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
5th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Telegraph Hill Partners, Europa	58/100
6th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 4 others	55/100
7th	Cayman Chem 1980, Ann Arbor (United States), Funding Raised	Develops bioreagents and offers preclinical services	-	Tehnopol Startup Incubator, Broadoak Capital Partners ... & 2 others	54/100
8th	Huwel Life 2015, Hyderabad (India), Seed	Molecular diagnostic solutions and products for the healthcare industry	$106K	BIRAC, AIC-CCMB & 2 others	54/100
9th	PL BioScience 2015, Aachen (Germany), Series A	Manufacturer of human platelet lysate products for cell culture applications	$13M	TechVision Fonds, Brightlands Venture Partners ... & 18 others	53/100
10th	Genetix Biotech 2001, Delhi (India), Unfunded	Provider of kits and reagents for life sciences companies	-	-	53/100
39th	Sirigen 2003, San Diego (United States), Acquired	High sensitivity fluorescence detection technologies for diagnostics and life science applications	$12.1M	Persistence Partners, IQ Capital & 7 others	42/100